Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph H. Capper
Joseph H. Capper is recorded as CEO and Board Member at Mimedx Group, Inc. (MDXG) and Board Member at Anika Therapeutics, Inc. (ANIK). Anika Therapeutics, Inc. reported in an 8-K filed June 24, 2025 that Joseph H. Capper was appointed Class II director, effective June 20, 2025. Mimedx Group, Inc. reported in an 8-K filed January 30, 2023 that Joseph H. Capper was appointed Board of Directors. Mimedx Group, Inc. reported in an 8-K filed January 30, 2023 that Joseph H. Capper was appointed Chief Executive Officer, effective January 27, 2023. Joseph H. Capper has spoken on 1 earnings call across 1 company, most recently for Mimedx Group, Inc. on July 30, 2025.
“As a result of this vote, Dr. Blanchard, Mr. Capper and Dr. Larsen were elected as Class II directors to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until his or her earlier resignation or removal.”
Anika Therapeutics, Inc. Form 8-K, filed June 24, 2025
· Read the filing
“Mr. Capper will also be appointed to the Board of Directors effective on the commencement of his employment with the Company.”
Mimedx Group, Inc. Form 8-K, filed January 30, 2023
· Read the filing
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
